HRES 709 · 113th Congress · Health
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2014-08-01)
Plain Language Summary
[AI summary unavailable — showing source text]
Recognizes the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and ways those challenges can be addressed.…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (6)
4 Democrats2 Republicans